secondary interstitial lung disease specific to childhood associated with a systemic disease
ORPHA: 2646991 Treatment Available
Overview
human disease
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| prednisone | oral tablet 1mg, 2.5mg, 5mg, 10mg, 20mg, 50mg; oral solution 5mg/5mL | FDA Approved | 13 | 1d |
Classification & Codes
Orphanet Code
ORPHA:264699secondary interstitial lung disease specific to childhood associated with a systemic disease
| Orphanet | ORPHA:264699 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO